Canada markets closed

PRQR Oct 2024 2.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.30000.0000 (0.00%)
As of 03:50PM EDT. Market open.
Full screen
Loading interactive chart...
  • GlobeNewswire

    ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit

    LEIDEN, Netherlands & CAMBRIDGE, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will participate in the RNA Editing Summit, June 18-20, 2024, in Boston, Massachusetts. As part of the conference program, Gerard Platenburg, Chief Scientific Officer and Co-Founder, ProQR Therapeutics, will present on June 20, 2024 at 2:00pm ET: “Developing Axiomer RNA Editing Techno

  • Simply Wall St.

    Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago

    Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...

  • GlobeNewswire

    ProQR Announces First Quarter 2024 Operating and Financial Results

    Preclinical proof of concept data for the AX-0810 program targeting NTCP for cholestatic diseases presented at ASGCT 27th Annual Meeting – Management to host webinar today at 8:00 am EDT to highlight dataMartin Maier, PhD nominated to Board with Annual General Meeting scheduled for May 22, 2024Continued strength of leading IP estate around ADAR-mediated RNA editing highlighted with successful defense of challenge to granted patent in Europe€102.7 million as of end of Q1 providing runway into mid